Impact of Zinc to Copper Ratio and Lipocalin 2 in Obese Patients Undergoing Sleeve Gastrectomy

Table 2

Clinical characteristics and metabolic variables in control group and group with morbid obesity (MO).

	Control group	MO group preoperative	MO group postoperative	ANOVA	value
Systolic BP (mmHg)	^a	^b	^a	8.03	0.002
Total cholesterol (mmol/L)	^a	^b	^a	6.52	0.008
Triglycerides (mmol/L)				2.15	0.158
HDL cholesterol (mmol/L)	^a	^b	^a	4.25	0.011
LDL cholesterol (mmol/L)	^a	^b	^a	4.01	0.026
HOMA-IR	^a	^b	^a	6. 11	0.005
Leptin (ng/mL)	^a	^b	^c	26.2	0.001
CRP (mg/L)	^a	^b	^c	12. 3	0.007
Lipocalin 2 (μg/L)	^a	^b		24.6	0.001
Albumin (g/dL)				2.65	0.244

Subjects with morbid obesity (MO) group. Statistically significant at . Duncan’s method was used to find the significant difference between two groups as follows: The same small letters indicate that there was no significant difference between the two groups, while the difference letters indicate that there was a significant difference between this two groups.